Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016

Watchlist Manager
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Logo
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
Watchlist
Price: 19.06 CNY -1.55%
Market Cap: 6.2B CNY
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Shandong Bailong Chuangyuan Bio-Tech Co Ltd

Wall Street analysts forecast Shandong Bailong Chuangyuan Bio-Tech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Bailong Chuangyuan Bio-Tech Co Ltd is 21.93 CNY with a low forecast of 21.72 CNY and a high forecast of 22.58 CNY.

Lowest Forecast
Wall Street Target
21.72 CNY
14% Upside
Average Forecast
Wall Street Target
21.93 CNY
15% Upside
Highest Forecast
Wall Street Target
22.58 CNY
18% Upside
Lowest
Price Target
21.72 CNY
14% Upside
Average
Price Target
21.93 CNY
15% Upside
Highest
Price Target
22.58 CNY
18% Upside
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Competitors:
Price Targets
ATM
A2 Milk Company Ltd
12% Downside
EFID
Edita Food Industries SAE
41% Upside
ABF
Associated British Foods PLC
16% Upside
SML
Synlait Milk Ltd
50% Downside
ATM
A2 Milk Company Ltd
12% Downside
EFID
Edita Food Industries SAE
41% Upside
ABF
Associated British Foods PLC
16% Upside
SML
Synlait Milk Ltd
50% Downside
AAC
Australian Agricultural Company Ltd
32% Upside
600305
Jiangsu Hengshun Vinegar-Industry Co Ltd
3% Downside
HERDEZ
Grupo Herdez SAB de CV
15% Upside
J
003000
Jinzai Food Group Co Ltd
37% Upside

Revenue
Forecast

Revenue Estimate
Shandong Bailong Chuangyuan Bio-Tech Co Ltd

For the last 4 years the compound annual growth rate for Shandong Bailong Chuangyuan Bio-Tech Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 34%.

20%
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shandong Bailong Chuangyuan Bio-Tech Co Ltd

For the last 4 years the compound annual growth rate for Shandong Bailong Chuangyuan Bio-Tech Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 40%.

21%
Past Growth
40%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shandong Bailong Chuangyuan Bio-Tech Co Ltd

For the last 4 years the compound annual growth rate for Shandong Bailong Chuangyuan Bio-Tech Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 35%.

24%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's stock price target?
Price Target
21.93 CNY

According to Wall Street analysts, the average 1-year price target for Shandong Bailong Chuangyuan Bio-Tech Co Ltd is 21.93 CNY with a low forecast of 21.72 CNY and a high forecast of 22.58 CNY.

What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Revenue forecast?
Projected CAGR
34%

For the last 4 years the compound annual growth rate for Shandong Bailong Chuangyuan Bio-Tech Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 34%.

What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Operating Income forecast?
Projected CAGR
40%

For the last 4 years the compound annual growth rate for Shandong Bailong Chuangyuan Bio-Tech Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 40%.

What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Net Income forecast?
Projected CAGR
35%

For the last 4 years the compound annual growth rate for Shandong Bailong Chuangyuan Bio-Tech Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 35%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 240,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.